{"transactions":[{"id":675178,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & VP of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-26T21:08:23.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 62,500 shares vest on 8/24/2027, and 187,500 shares vest pro rata on the 24th of each month thereafter for 36 consecutive months."}],"balance_after":250000,"derivative":{"exercise_price":0.746,"expiration_date":"2036-08-24","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000914190-26-000137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000137/form4.xml","form_type":"4"}},{"id":728483,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-23T22:28:40.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of Envoy Medical, Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All restricted stock units subject to the RSU Award Grant Notice dated June 19, 2026, will vest as of the date of the official notification by the U.S. Food and Drug Administration (FDA) that it has granted approval (including approval with conditions) for its Acclaim cochlear implant, provided that such announcement occurs during the performance period beginning June 19, 2026 and ending on June 18, 2030."}],"balance_after":1000000,"derivative":{"expiration_date":"2030-06-18","underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000100/form4.xml","form_type":"4"}},{"id":728482,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-23T22:28:40.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 250,000 shares vest on 6/19/27, and 750,000 shares vest pro rata on the 19th of each month thereafter for 36 consecutive months."}],"balance_after":1000000,"derivative":{"exercise_price":0.634,"expiration_date":"2036-06-19","underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000100/form4.xml","form_type":"4"}},{"id":749053,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:28:22.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":32856,"price":0.599,"value":19680.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":329946,"source":{"system":"sec-edgar","filing":"0000914190-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000095/form4.xml","form_type":"4"}},{"id":805144,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":36296,"kind":"person","name":"McKhann Chas","position":1,"cik":"0001631746","reported_name":"McKhann Chas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T20:32:04.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning on 5/15/2026, options to purchase Class A Common Stock will vest pro rata on the 15th of each month for 36 consecutive months."}],"balance_after":100000,"derivative":{"exercise_price":0.72,"expiration_date":"2036-04-15","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000914190-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631746/000091419026000077/form4.xml","form_type":"4"}},{"id":900264,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:51:51.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":312500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":312500},"source":{"system":"sec-edgar","filing":"0000914190-26-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000028/form4.xml","form_type":"4"}},{"id":900263,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:51:51.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":187500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000914190-26-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000028/form4.xml","form_type":"4"}},{"id":900262,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T21:51:51.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":0.4,"value":125000.0,"ownership":{"direct":true},"balance_after":332500,"source":{"system":"sec-edgar","filing":"0000914190-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000028/form4.xml","form_type":"4"}},{"id":901327,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":212500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":212500},"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":901326,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":127500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":901325,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":212500,"price":0.4,"value":85000.0,"ownership":{"direct":true},"balance_after":212500,"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":900260,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":62500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":900259,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":37500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":900258,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"balance_after":297090,"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":901024,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:47:12.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":96150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":96150,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":96150},"source":{"system":"sec-edgar","filing":"0000914190-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000091419026000026/form4.xml","form_type":"4"}},{"id":901023,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:47:12.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":57690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":57690,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":57690},"source":{"system":"sec-edgar","filing":"0000914190-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000091419026000026/form4.xml","form_type":"4"}},{"id":901022,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T16:47:12.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":96150,"price":0.4,"value":38460.0,"ownership":{"direct":true},"balance_after":174037,"source":{"system":"sec-edgar","filing":"0000914190-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000091419026000026/form4.xml","form_type":"4"}},{"id":900298,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":1000000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":900297,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":600000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":900296,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":0.4,"value":400000.0,"ownership":{"direct":true},"balance_after":1050000,"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":900573,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant Shares (Series A-2)","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":18750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1 Warrants and Series A-2 Warrants (the \"Common Warrants\") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the \"Stockholder Approval Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-2 Warrants expire on the earlier of (i) the sixty-month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has received U.S. Food and Drug Administration approval for its Acclaim cochlear implant (the \"Series A-2 Milestone Event\")."}],"balance_after":18750000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":18750000},"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":900572,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant Shares (Series A-1)","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":11250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1 Warrants and Series A-2 Warrants (the \"Common Warrants\") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the \"Stockholder Approval Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Warrants expire on the earlier of (i) the twenty-four month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration for its Acclaim cochlear implant (the \"Series A-1 Milestone Event\")."}],"balance_after":11250000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":11250000},"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":900571,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":18750000,"price":0.4,"value":7500000.0,"ownership":{"direct":true},"balance_after":21703607,"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":914623,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T22:45:38.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 3,750 shares vest on 2/5/2027, and 11,250 shares vest pro rata on the 5th of each month thereafter for 36 consecutive months."}],"balance_after":15000,"derivative":{"exercise_price":0.53,"expiration_date":"2036-02-05","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000914190-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000015/form4.xml","form_type":"4"}},{"id":913908,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T22:45:09.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 50,000 shares vest on 2/5/2027, and 150,000 shares vest pro rata on the 5th of each month thereafter for 36 consecutive months."}],"balance_after":200000,"derivative":{"exercise_price":0.53,"expiration_date":"2036-02-05","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000914190-26-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000014/form4.xml","form_type":"4"}},{"id":973839,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-10T22:49:36.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":18105,"price":0.713,"value":12908.865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":234590,"source":{"system":"sec-edgar","filing":"0000914190-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419025000054/form4.xml","form_type":"4"}},{"id":978593,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":72134,"kind":"person","name":"Smith-Gomez Janis","position":1,"cik":"0001995670","reported_name":"Smith-Gomez Janis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T22:42:43.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000914190-25-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419025000052/form4.xml","form_type":"4"}},{"id":978591,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T22:41:17.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000914190-25-000050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419025000050/form4.xml","form_type":"4"}},{"id":979268,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":72160,"kind":"person","name":"Crowe Michael Curtis","position":1,"cik":"0002026683","reported_name":"Crowe Michael Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T17:42:19.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000914190-25-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026683/000091419025000051/form4.xml","form_type":"4"}},{"id":979024,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T17:40:57.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000914190-25-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000091419025000049/form4.xml","form_type":"4"}},{"id":978646,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T17:40:13.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000914190-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419025000048/form4.xml","form_type":"4"}},{"id":1045714,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.48,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045713,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.48,"expiration_date":"2027-06-26","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045712,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045711,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2028-03-11","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045710,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.2,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045709,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045708,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.97,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045707,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.97,"expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045706,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":2.25,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045705,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045704,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":3.04,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045703,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":3.04,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045702,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":1.24,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045701,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1090520,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-07-08T10:37:33.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the promissory note issuance effective March 6, 2025 and the closing of the final funding on June 26, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on July 2, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.48,"exercise_date":"2025-06-26","expiration_date":"2027-06-26","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-012617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325012617/form4.xml","form_type":"4"}},{"id":1110736,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-13T20:10:30.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.47,"value":3675.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.4799 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-25-011661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011661/form4.xml","form_type":"4"}},{"id":1115929,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-10T20:11:23.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.46,"value":14600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.4981 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001062993-25-011320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011320/form4.xml","form_type":"4"}},{"id":1117208,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-10T00:58:13.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7742,"price":1.2927,"value":10008.0834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":216485,"source":{"system":"sec-edgar","filing":"0001062993-25-011296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011296/form4.xml","form_type":"4"}},{"id":1117207,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-10T00:58:13.000Z","date":"2024-11-30","kind":"grant","planned":false,"acquired":true,"shares":5165,"price":1.94,"value":10020.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":208743,"source":{"system":"sec-edgar","filing":"0001062993-25-011296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011296/form4.xml","form_type":"4"}},{"id":1132891,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-27","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":1.6478,"value":57673.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6345 to $1.65 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1132890,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-23","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":1.6433,"value":21362.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6333 to $1.6497 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1132889,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.6834,"value":3366.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6875 to $1.6794 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1207516,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-03-13T16:06:56.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the promissory note issuance effective March 6, 2025 and the closing of the initial funding on March 11, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on March 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.35,"exercise_date":"2025-03-11","expiration_date":"2028-03-11","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-005363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325005363/form4.xml","form_type":"4"}},{"id":1321381,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"ten_percent_owner":true}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"ten_percent_owner":true}}],"security":"Series A Preferred Stock, par value $0.0001 per share","published_at":"2024-12-26T22:39:35.000Z","date":"2023-12-20","kind":"exercise","planned":false,"acquired":false,"shares":373333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"As disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on December 20, 2024, pursuant to the Conversion and Waiver Agreement between the Issuer and the Sponsor, among other things, the Issuer made a voluntary, temporary reduction in the conversion price, pursuant to the terms of the Certificate of Designation, of all of the outstanding shares of Preferred Stock effective December 20, 2024 through January 20, 2025 from $11.50 per share of Common Stock issuable upon conversion of a share of Preferred Stock to $3.63, with the conversion ratio determined by dividing the $10.00 original issue price of the Preferred Stock by such conversion price."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 20, 2024, Anzu SPAC GP I LLC (the \"Sponsor\") converted 373,333 shares of Series A Preferred Stock, par value $0.0001 (\"Preferred Stock\") of Envoy Medical, Inc. (the \"Issuer\") into 1,028,986 shares of Class A Common Stock, par value $0.0001 per share (\"Common Stock\") pursuant to the terms set forth in the Certificate of Designation for the Preferred Stock (the \"Certificate of Designation\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of Preferred Stock have no expiration date. The shares of Preferred Stock are subject to mandatory conversion into shares of Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Preferred Stock to shares of Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Preferred Stock have no expiration date. The shares of Preferred Stock are subject to mandatory conversion into shares of Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Preferred Stock to shares of Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Preferred Stock have no expiration date. The shares of Preferred Stock are subject to mandatory conversion into shares of Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Preferred Stock to shares of Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On December 20, 2024, Anzu SPAC GP I LLC (the \"Sponsor\") converted 373,333 shares of Series A Preferred Stock, par value $0.0001 (\"Preferred Stock\") of Envoy Medical, Inc. (the \"Issuer\") into 1,028,986 shares of Class A Common Stock, par value $0.0001 per share (\"Common Stock\") pursuant to the terms set forth in the Certificate of Designation for the Preferred Stock (the \"Certificate of Designation\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2126667,"derivative":{"exercise_price":3.63,"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":1028986},"source":{"system":"sec-edgar","filing":"0001140361-24-050420","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000114036124050420/form4.xml","form_type":"4"}},{"id":1321380,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"ten_percent_owner":true}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2024-12-26T22:39:35.000Z","date":"2024-12-23","kind":"other","planned":false,"acquired":false,"shares":2028986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata distribution in-kind by the Sponsor to its members for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-24-050420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000114036124050420/form4.xml","form_type":"4"}},{"id":1321379,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"ten_percent_owner":true}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2024-12-26T22:39:35.000Z","date":"2024-12-20","kind":"exercise","planned":false,"acquired":true,"shares":1028986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 20, 2024, Anzu SPAC GP I LLC (the \"Sponsor\") converted 373,333 shares of Series A Preferred Stock, par value $0.0001 (\"Preferred Stock\") of Envoy Medical, Inc. (the \"Issuer\") into 1,028,986 shares of Class A Common Stock, par value $0.0001 per share (\"Common Stock\") pursuant to the terms set forth in the Certificate of Designation for the Preferred Stock (the \"Certificate of Designation\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2028986,"source":{"system":"sec-edgar","filing":"0001140361-24-050420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000114036124050420/form4.xml","form_type":"4"}},{"id":1321686,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-12-26T17:52:27.000Z","date":"2024-12-23","kind":"other","planned":false,"acquired":true,"shares":34705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were received by the reporting person in connection with a pro-rata distribution in-kind by Anzu SPAC GP I LLC to its members for no consideration."}],"balance_after":77887,"source":{"system":"sec-edgar","filing":"0001140361-24-050422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000114036124050422/form4.xml","form_type":"4"}},{"id":1328291,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-12-17T16:42:31.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued on August 27, 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on December 17, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.2,"exercise_date":"2024-12-11","expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-020770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324020770/form4.xml","form_type":"4"}},{"id":1331837,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-12-13T21:10:57.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":16694,"price":0.06,"value":1001.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":110987,"derivative":{"exercise_price":11.5,"expiration_date":"2028-09-29","underlying":"Class A Common Stock","underlying_shares":16694},"source":{"system":"sec-edgar","filing":"0001062993-24-020597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324020597/form4.xml","form_type":"4"}},{"id":1331836,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-12-13T21:10:57.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":94293,"price":0.055,"value":5186.115,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":94293,"derivative":{"exercise_price":11.5,"expiration_date":"2028-09-29","underlying":"Class A Common Stock","underlying_shares":94293},"source":{"system":"sec-edgar","filing":"0001062993-24-020597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324020597/form4.xml","form_type":"4"}},{"id":1353634,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T21:32:31.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.2795,"value":5698.75,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001062993-24-019574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324019574/form4.xml","form_type":"4"}},{"id":1355484,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2024-11-21T23:00:32.000Z","date":"2024-11-19","kind":"other","planned":false,"acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution in-kind by Anzu SPAC GP I LLC (the \"Sponsor\") to its members for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001062993-24-019529","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324019529/form4.xml","form_type":"4"}},{"id":1355763,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-21T18:04:00.000Z","date":"2024-11-19","kind":"other","planned":false,"acquired":true,"shares":18182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were received by the reporting person in connection with a pro-rata distribution in-kind by Anzu SPAC GP I LLC to its members for no consideration."}],"balance_after":43182,"source":{"system":"sec-edgar","filing":"0001062993-24-019530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000106299324019530/form4.xml","form_type":"4"}},{"id":1409339,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-11T20:50:47.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":3.33,"value":13320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average price. These shares of Class A Common Stock were purchased in multiple transactions at prices ranging from $3.28 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001062993-24-016486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324016486/form4.xml","form_type":"4"}},{"id":1409338,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-11T20:50:47.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.2,"value":3200.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001062993-24-016486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324016486/form4.xml","form_type":"4"}},{"id":1419811,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-08-29T16:06:32.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued on August 27, 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on August 28, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.97,"exercise_date":"2024-08-27","expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-015872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324015872/form4.xml","form_type":"4"}},{"id":1436191,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":72160,"kind":"person","name":"Crowe Michael Curtis","position":1,"cik":"0002026683","reported_name":"Crowe Michael Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-12T16:07:05.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 6,250 shares vest on 08/08/2025, and the remaining 18,750 shares vest pro rata on the 8th of each month thereafter for 36 consecutive months."}],"balance_after":25000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-08","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-24-014844","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026683/000106299324014844/form4.xml","form_type":"4"}},{"id":1449272,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-07-24T16:43:08.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued in February 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Exhibit 10.1 of the Issuer's 10-Q as filed with the SEC on May 15, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":2.25,"exercise_date":"2024-07-22","expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-24-014054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324014054/form4.xml","form_type":"4"}},{"id":1468543,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-26T20:06:40.000Z","date":"2024-06-24","kind":"other","planned":false,"acquired":true,"shares":10176,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Family Education Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Cornerstone Growth Group, LP and Cornerstone Growth Group II, LP, of which the reporting person was a non-managing member and did not have voting, dispositive or other rights."}],"balance_after":12720,"source":{"system":"sec-edgar","filing":"0001062993-24-013065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324013065/form4.xml","form_type":"4"}},{"id":1468542,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-26T20:06:40.000Z","date":"2024-06-24","kind":"other","planned":false,"acquired":true,"shares":74784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Cornerstone Growth Group, LP and Cornerstone Growth Group II, LP, of which the reporting person was a non-managing member and did not have voting, dispositive or other rights."}],"balance_after":195615,"source":{"system":"sec-edgar","filing":"0001062993-24-013065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324013065/form4.xml","form_type":"4"}},{"id":1500123,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-05-28T16:13:49.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued in February 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail under Item 1.01 in the Issuer's 8-K as filed with the SEC on May 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":3.04,"exercise_date":"2024-05-23","expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-24-011337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324011337/form4.xml","form_type":"4"}},{"id":1602616,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-03-04T17:19:24.000Z","date":"2024-02-27","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":1.24,"exercise_date":"2024-02-27","expiration_date":"2026-02-26","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-005235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324005235/form4.xml","form_type":"4"}},{"id":1723572,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-12-04T16:57:21.000Z","date":"2023-11-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"shares","element":"transactionShares","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":1000000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001062993-23-021838","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323021838/form4a.xml","form_type":"4/A","original_submission_date":"2023-11-22"}},{"id":1730097,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-24T21:09:42.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":2380,"price":0.92,"value":2189.6,"ownership":{"direct":true},"balance_after":120831,"source":{"system":"sec-edgar","filing":"0001062993-23-021438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323021438/form4.xml","form_type":"4"}},{"id":1730096,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-24T21:09:42.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.98,"value":9800.0,"ownership":{"direct":true},"balance_after":118451,"source":{"system":"sec-edgar","filing":"0001062993-23-021438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323021438/form4.xml","form_type":"4"}},{"id":1730951,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-11-22T16:11:45.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The original filing on October 3, 2023 contained a calculation error and the amount shown in column 7 now reflects the correct number of shares\nissuable upon conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":1100000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":956522},"source":{"system":"sec-edgar","filing":"0001062993-23-021360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323021360/form4.xml","form_type":"4"}},{"id":1758732,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T21:25:45.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":879749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 659,811 shares vest on 10/15/2023, and 219,938 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":879749,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":879749},"source":{"system":"sec-edgar","filing":"0001062993-23-019479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323019479/form4.xml","form_type":"4"}},{"id":1758731,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66142,"kind":"person","name":"Patel Mona Chetan","position":1,"cik":"0001995769","reported_name":"Patel Mona Chetan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T20:11:37.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":25000,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-019443","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323019443/form4.xml","form_type":"4"}},{"id":1758970,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":45655,"kind":"person","name":"Wells David R.","position":1,"cik":"0001480371","reported_name":"Wells David R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T20:09:42.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":293250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 73,313 shares vest on 10/15/2024, and the remaining 219,937 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":293250,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":293250},"source":{"system":"sec-edgar","filing":"0001062993-23-019440","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480371/000106299323019440/form4.xml","form_type":"4"}},{"id":1758730,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":72134,"kind":"person","name":"Smith-Gomez Janis","position":1,"cik":"0001995670","reported_name":"Smith-Gomez Janis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T20:07:48.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":25000,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-019436","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323019436/form4.xml","form_type":"4"}},{"id":1759023,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T17:29:20.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Options to purchase 15,625 shares vest on 10/15/2024, and the remaining 46,875 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 15,625 shares vest on 10/15/2024, and the remaining 46,875 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":62500,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001062993-23-019481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000106299323019481/form4.xml","form_type":"4"}},{"id":1758764,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T16:13:35.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":62500,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001062993-23-019448","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299323019448/form4.xml","form_type":"4"}},{"id":1766389,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":2490000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F10","text":"On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":2490000},"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766388,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"other","planned":false,"acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"shares","element":"transactionShares","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2490000,"derivative":{"underlying":"Class A Common Stock, par value $0.001 per share","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766387,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock."},{"field":"shares","element":"transactionShares","label":"F9","text":"On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":4990000,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":5510000},"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766386,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"other","planned":false,"acquired":true,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"shares","element":"transactionShares","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2500000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":2173913},"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766385,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":false,"nature":"See footnote 6"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"shares","element":"transactionShares","label":"F7","text":"On April 17, 2023, the Issuer entered into a subscription agreement with the Sponsor pursuant to which AICP III L.P., Anzu Industrial Capital Partners III, L.P. and Anzu Industrial Capital Partners III QP, L.P., each an affiliate of the Sponsor, paid an aggregate $10,000,000 in exchange for 1,000,000 shares of Series A preferred stock, par value $0.0001 per share (\"Series A Preferred Stock\"), which shares were issued to such affiliates on September 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"These shares of Series A Preferred Stock have no expiration date. These shares of Series A Preferred Stock are subject to mandatory conversion into shares of Class A Common Stock at the Issuer's sole discretion upon the occurrence of certain events specified in the Certificate of Designation. In addition, holders of Series A Preferred Stock have the right, at any time at such preferred stockholder's option, to convert each share of Series A Preferred Stock to shares of Class A Common Stock based on the ratio determined by dividing the Original Issuance Price of $10.00 per share by the Conversion Price of $11.50 per share, subject to certain customary adjustments in the event of certain events affecting the price of the Class A Common Stock, such as stock splits and combinations, or the distribution of options, rights or warrants, as described in the Certificate of Designation."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":1000000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766384,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"other","planned":false,"acquired":false,"shares":490000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Sponsor transferred an aggregate of 490,000 shares of Class A Common Stock to various third parties pursuant to (i) the extension support agreements between the Issuer, the Sponsor and several unaffiliated third parties and (ii) the side letter agreements between the Sponsor and certain institutional investors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"1,000,000 of these shares have vested. The remaining 1,000,000 shares remain unvested and subject to forfeiture, and will vest upon the U.S. Food and Drug Administration's approval of the Issuer's Acclaim cochlear implant device or upon a change of control of the Issuer. All 2,000,000 shares are subject to a contractual lock-up agreement and may only be transferred in accordance with the terms thereof."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1766383,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":84754,"kind":"organization","name":"Anzu SPAC GP I LLC","position":1,"cik":"0001846378","reported_name":"Anzu SPAC GP I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":84755,"kind":"person","name":"Haring-Smith Whitney","position":2,"cik":"0001846535","reported_name":"Haring-Smith Whitney","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:58:59.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":2490000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued in connection with the automatic conversion of an equal number of shares of Class B Common Stock, par value $0.0001 per share (\"Class B Common Stock\"), which converted to Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\"), upon the closing (the \"Closing\") of the business combination between Anzu Special Acquisition Corp. I and Envoy Medical Corporation (the \"Business Combination\").... (continued)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) ...Prior to the Closing, Anzu SPAC GP I LLC (the \"Sponsor\") beneficially owned 10,500,000 shares of Class B Common Stock. In connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock and exchanged 2,500,000 shares of Class B Common Stock for an equal number of shares of Series A Preferred Stock, par value $0.0001 (\"Series A Preferred Stock\") in a private exchange offer. The Issuer's remaining 2,490,000 shares of Class B Common Stock automatically converted to an equal number of shares of Class A Common Stock upon the Closing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Dr. Whitney Haring-Smith shares voting and investment control over shares held by the Sponsor, and, as a result, may be deemed to beneficially own the securities reported herein. Dr. Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."}],"balance_after":2490000,"source":{"system":"sec-edgar","filing":"0001062993-23-018937","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323018937/form4.xml","form_type":"4"}},{"id":1767185,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":44520,"kind":"person","name":"Huskins Priya Cherian","position":1,"cik":"0001419882","reported_name":"Huskins Priya Cherian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:52:51.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-018936","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419882/000106299323018936/form4.xml","form_type":"4"}},{"id":1767184,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":44520,"kind":"person","name":"Huskins Priya Cherian","position":1,"cik":"0001419882","reported_name":"Huskins Priya Cherian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:52:51.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Huskins resigned as a director of Anzu."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001062993-23-018936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419882/000106299323018936/form4.xml","form_type":"4"}},{"id":1767306,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":42586,"kind":"person","name":"Hirsch Daniel J.","position":1,"cik":"0001453077","reported_name":"Hirsch Daniel J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:46:09.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-018934","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453077/000106299323018934/form4.xml","form_type":"4"}},{"id":1767305,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":42586,"kind":"person","name":"Hirsch Daniel J.","position":1,"cik":"0001453077","reported_name":"Hirsch Daniel J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:46:09.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001062993-23-018934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453077/000106299323018934/form4.xml","form_type":"4"}},{"id":1766866,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":47815,"kind":"person","name":"DEWBREY DIANE L","position":1,"cik":"0001200125","reported_name":"DEWBREY DIANE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:42:19.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-018933","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200125/000106299323018933/form4.xml","form_type":"4"}},{"id":1766865,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":47815,"kind":"person","name":"DEWBREY DIANE L","position":1,"cik":"0001200125","reported_name":"DEWBREY DIANE L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-04T01:42:19.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination (the \"Business Combination\") between Anzu Special Acquisition Corp I (\"Anzu\") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001062993-23-018933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200125/000106299323018933/form4.xml","form_type":"4"}},{"id":1767497,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2023-10-03T21:50:55.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-23-018935","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000106299323018935/form4.xml","form_type":"4"}},{"id":1767496,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66206,"kind":"person","name":"Kantor Susan","position":1,"cik":"0001673071","reported_name":"Kantor Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2023-10-03T21:50:55.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001062993-23-018935","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673071/000106299323018935/form4.xml","form_type":"4"}},{"id":1766856,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-10-03T18:32:58.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":869565,"price":10,"value":8695650.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the conversion of Reporting Person's $10,000,000 Envoy Bridge Note into shares of Series A Preferred Stock at $10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."}],"balance_after":869565,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001062993-23-018900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323018900/form4.xml","form_type":"4"}},{"id":1766855,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"$10,000,000 Convertible Note","published_at":"2023-10-03T18:32:58.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the conversion of Reporting Person's $10,000,000 Envoy Bridge Note into shares of Series A Preferred Stock at $10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."}],"balance_after":0,"derivative":{"underlying":"Series A Preferred Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001062993-23-018900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323018900/form4.xml","form_type":"4"}}],"next_cursor":"2023-10-03T18:32:58.000000Z,1766855"}